Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer

IMPORTANCE: Despite recent breakthroughs in therapy, advanced lung cancer still poses a therapeutic challenge. The survival profile of patients with metastatic lung cancer remains poorly understood by metastatic disease type (ie, de novo stage IV vs distant recurrence). OBJECTIVE: To evaluate the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Chloe C., Wu, Julie T., Choi, Eunji, Myall, Nathaniel J., Neal, Joel W., Kurian, Allison W., Stehr, Henning, Wood, Douglas, Henry, Solomon M., Backhus, Leah M., Leung, Ann N., Wakelee, Heather A., Han, Summer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523163/
https://www.ncbi.nlm.nih.gov/pubmed/37751203
http://dx.doi.org/10.1001/jamanetworkopen.2023.35813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523163/
https://www.ncbi.nlm.nih.gov/pubmed/37751203
http://dx.doi.org/10.1001/jamanetworkopen.2023.35813

Ejemplares similares